Related references
Note: Only part of the references are listed.Aldosterone Induces Vascular Damage A Wave Reflection Analysis Study
Chi-Sheng Hung et al.
HYPERTENSION (2019)
Primary Aldosteronism JACC State-of-the-Art Review
Gian Paolo Rossi
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Acute aortic syndromes: diagnosis and management, an update
Eduardo Bossone et al.
EUROPEAN HEART JOURNAL (2018)
Mineralocorticoid receptor antagonism protects the aorta from vascular smooth muscle cell proliferation and collagen deposition in a rat model of adrenal aldosterone-producing adenoma
Yongji Yan et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2018)
Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis
Silvia Monticone et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Primary Aldosteronism: Practical Approach to Diagnosis and Management
James Brian Byrd et al.
CIRCULATION (2018)
Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice
Silvia Monticone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism
Sophocles Chrissobolis
CURRENT HYPERTENSION REVIEWS (2017)
NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage
Thiago Bruder-Nascimento et al.
CIRCULATION (2016)
Aldosterone in vascular and metabolic dysfunction
James M. Luther
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2016)
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
John W. Funder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Aortic dissection
Christoph A. Nienaber et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
A Case of Glucocorticoid Remediable Aldosteronism and Thoracoabdominal Aneurysms
Anahita Shahrrava et al.
CASE REPORTS IN ENDOCRINOLOGY (2016)
Aldosterone Promotes Vascular Remodeling by Direct Effects on Smooth Muscle Cell Mineralocorticoid Receptors
Dafina Pruthi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Endothelial Cell Mineralocorticoid Receptors Regulate Deoxycorticosterone/Salt-Mediated Cardiac Remodeling and Vascular Reactivity But Not Blood Pressure
Amanda J. Rickard et al.
HYPERTENSION (2014)
Observational Study Mortality in Treated Primary Aldosteronism The German Conn's Registry
Martin Reincke et al.
HYPERTENSION (2012)
T Regulatory Lymphocytes Prevent Aldosterone-Induced Vascular Injury
Daniel A. Kasal et al.
HYPERTENSION (2012)
Eplerenone Reduced Lesion Size in Early but Not Advanced Atherosclerosis in Apolipoprotein E-Deficient Mice
Ayelet Raz-Pasteur et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2012)
Effects of Spironolactone on Cerebral Vessel Structure in Rats With Sustained Hypertension
Christine S. Rigsby et al.
AMERICAN JOURNAL OF HYPERTENSION (2011)
Simultaneous surgery for chronic aortic dissection and adrenal adenoma with primary aldosteronism
Hidekazu Hirai et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2010)
Aldosterone induces arterial stiffness in absence of oxidative stress and endothelial dysfunction
Eyal Leibovitz et al.
JOURNAL OF HYPERTENSION (2009)
Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study
Stella Douma et al.
LANCET (2008)
Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats
Christine' S. Rigsby et al.
MICROVASCULAR RESEARCH (2007)
Is primary hyperaldosteronism a risk factor for aortic dissection?
S. Hinan Ahmed et al.
CARDIOLOGY (2007)
Primary aldosteronism and hypertensive disease
L Mosso et al.
HYPERTENSION (2003)
Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling
Q Pu et al.
HYPERTENSION (2003)
Spironolactone improves angiotensin-induced vascular changes and oxidative stress
A Virdis et al.
HYPERTENSION (2002)
Mineralocorticoid receptor antagonism in experimental atherosclerosis
S Rajagopalan et al.
CIRCULATION (2002)
ETA receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats
JB Park et al.
HYPERTENSION (2001)